1.Bikle DD: Vitamin D metabolism, mechanism of action, and clinical applications. Chem Biol 2014, 21(3):319–329.
2.Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF et al: Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002, 51(7):2294–2300.
3.Chandel N, Ayasolla K, Wen H, Lan X, Haque S, Saleem MA, Malhotra A, Singhal PC: Vitamin D receptor deficit induces activation of renin angiotensin system via SIRT1 modulation in podocytes. Exp Mol Pathol 2017, 102(1):97–105.
4.Yang L, Wu L, Fan Y, Ma J: Associations among four polymorphisms (BsmI, FokI, TaqI and ApaI) of vitamin D receptor gene and end-stage renal disease: a meta-analysis. Arch Med Res 2015, 46(1):1–7.
5.Yang L, Wu L, Fan Y, Ma J: Vitamin D receptor gene polymorphisms in association with diabetic nephropathy: a systematic review and meta-analysis. BMC Med Genet 2017, 18(1):95.
6.Zhou TB, Jiang ZP, Huang MF: Association of vitamin D receptor BsmI (rs1544410) gene polymorphism with the chronic kidney disease susceptibility. J Recept Signal Transduct Res 2015, 35(1):54–57.
7.Nosratabadi R, Arababadi MK, Salehabad VA, Shamsizadeh A, Mahmoodi M, Sayadi AR, Kennedy D: Polymorphisms within exon 9 but not intron 8 of the vitamin D receptor are associated with the nephropathic complication of type–2 diabetes. Int J Immunogenet 2010, 37(6):493–497.
8.Liu W, Chen M, Li M, Ma H, Tong S, Lei Y, Qi L: Vitamin D receptor gene (VDR) polymorphisms and the urolithiasis risk: an updated meta-analysis based on 20 case-control studies. Urolithiasis 2014, 42(1):45–52.
9.Zhang P, Nie W, Jiang H: Effects of vitamin D receptor polymorphisms on urolithiasis risk: a meta-analysis. BMC Med Genet 2013, 14:104.
10.Yin F, Liu J, Fan MX, Zhou XL, Zhang XL: Association between the vitamin D receptor gene polymorphisms and diabetic nephropathy risk: A meta-analysis. Nephrology (Carlton) 2018, 23(2):107–116.
11.Liu Z, Liu L, Chen X, He W, Yu X: Associations study of vitamin D receptor gene polymorphisms with diabetic microvascular complications: a meta-analysis. Gene 2014, 546(1):6–10.
12.Matana A, Popovic M, Torlak V, Punda A, Barbalic M, Zemunik T: Effects of genetic variants on serum parathyroid hormone in hyperparathyroidism and end-stage renal disease patients: A systematic review and meta-analysis. Medicine (Baltimore) 2018, 97(21):e10834.
13.Guha M, Bankura B, Ghosh S, Pattanayak AK, Ghosh S, Pal DK, Puri A, Kundu AK, Das M: Polymorphisms in CaSR and CLDN14 Genes Associated with Increased Risk of Kidney Stone Disease in Patients from the Eastern Part of India. PLoS One 2015, 10(6):e0130790.
14.Han R DX, Su B, Yang W, Liu H, Song D: [Association between TaqI, ApaI of vitamin D receptor gene polymorphism and type 2 diabetic nephropathy of the Han nationality in Kunming]. China Medical Herald 2015, 12(9):69–72.
15.Goknar N, Oktem F, Torun E, Gok O, Demir AD, Kucukkoc M, Kilic U: The role of vitamin D receptor gene polymorphisms in Turkish infants with urolithiasis. Ren Fail 2016, 38(4):545–551.
16.Ozkaya O, Soylemezoglu O, Misirlioglu M, Gonen S, Buyan N, Hasanoglu E: Polymorphisms in the vitamin D receptor gene and the risk of calcium nephrolithiasis in children. Eur Urol 2003, 44(1):150–154.
17.Gunes S, Bilen CY, Kara N, Asci R, Bagci H, Yilmaz AF: Vitamin D receptor gene polymorphisms in patients with urolithiasis. Urol Res 2006, 34(1):47–52.
18.Seyhan S, Yavascaoglu I, Kilicarslan H, Dogan HS, Kordan Y: Association of vitamin D receptor gene Taq I polymorphism with recurrent urolithiasis in children. Int J Urol 2007, 14(12):1060–1062.
19.Aykan S, Tuken M, Gunes S, Akin Y, Ozturk M, Seyhan S, Yuruk E, Temiz MZ, Yilmaz AF, Nguyen DP: ApaL1 urokinase and Taq1 vitamin D receptor gene polymorphisms in first-stone formers, recurrent stone formers, and controls in a Caucasian population. Urolithiasis 2016, 44(2):109–115.
20.Cakir OO, Yilmaz A, Demir E, Incekara K, Kose MO, Ersoy N: Association of the BsmI, ApaI, TaqI, Tru9I and FokI Polymorphisms of the Vitamin D Receptor Gene with Nephrolithiasis in the Turkish Population. Urol J 2016, 13(1):2509–2518.
21.Tripathi G, Sharma R, Sharma RK, Gupta SK, Sankhwar SN, Agrawal S: Vitamin D receptor genetic variants among patients with end-stage renal disease. Ren Fail 2010, 32(8):969–977.
22.Mittal RD, Mishra DK, Srivastava P, Manchanda P, Bid HK, Kapoor R: Polymorphisms in the vitamin D receptor and the androgen receptor gene associated with the risk of urolithiasis. Indian J Clin Biochem 2010, 25(2):119–126.
23.Wang LY, Zhang P, Wang HF, Qin ZW, Wei KB, Lv XA: Association of vitamin D receptor gene polymorphisms with end-stage renal disease and the development of high-turnover renal osteodystrophy in a Chinese population. Genet Mol Res 2016, 15(2).
24.Martin RJ, McKnight AJ, Patterson CC, Sadlier DM, Maxwell AP, Warren UKGSG: A rare haplotype of the vitamin D receptor gene is protective against diabetic nephropathy. Nephrol Dial Transplant 2010, 25(2):497–503.
25.Mossetti G, Vuotto P, Rendina D, Numis FG, Viceconti R, Giordano F, Cioffi M, Scopacasa F, Nunziata V: Association between vitamin D receptor gene polymorphisms and tubular citrate handling in calcium nephrolithiasis. J Intern Med 2003, 253(2):194–200.
26.Moyano MJ, Gomez de Tejada MJ, Garcia Lozano R, Moruno R, Ortega R, Marti V, Sanchez Palencia R, Miranda MJ, Palma A, Perez Cano R: [Alterations in bone mineral metabolism in patients with calcium kidney stone disease and polymorphism of vitamin D receptor. Preliminary results]. Nefrologia 2007, 27(6):694–703.
27.Bucan K, Ivanisevic M, Zemunik T, Boraska V, Skrabic V, Vatavuk Z, Galetovic D, Znaor L: Retinopathy and nephropathy in type 1 diabetic patients—association with polymorphysms of vitamin D-receptor, TNF, Neuro-D and IL–1 receptor 1 genes. Coll Antropol 2009, 33 Suppl 2:99–105.
28.Zhang H, Wang J, Yi B, Zhao Y, Liu Y, Zhang K, Cai X, Sun J, Huang L, Liao Q: BsmI polymorphisms in vitamin D receptor gene are associated with diabetic nephropathy in type 2 diabetes in the Han Chinese population. Gene 2012, 495(2):183–188.
29.Ghorbanihaghjo A, Argani H, Samadi N, Valizadeh S, Halajzadeh J, Yousefi B, Rashtchizadeh N: Relationship between vitamin D receptor gene FokI and ApaI polymorphisms and serum levels of fetuin-A, vitamin D, and parathyroid hormone in patients on hemodialysis. Iran J Kidney Dis 2014, 8(5):394–400.
30.Singh PK, van den Berg PR, Long MD, Vreugdenhil A, Grieshober L, Ochs-Balcom HM, Wang J, Delcambre S, Heikkinen S, Carlberg C et al: Integration of VDR genome wide binding and GWAS genetic variation data reveals co-occurrence of VDR and NF-kappaB binding that is linked to immune phenotypes. BMC Genomics 2017, 18(1):132.
31.Tian Y, Lv G, Yang Y, Zhang Y, Yu R, Zhu J, Xiao L, Zhu J: Effects of vitamin D on renal fibrosis in diabetic nephropathy model rats. Int J Clin Exp Pathol 2014, 7(6):3028–3037.
32.Cinar N, Harmanci A, Yildiz BO, Bayraktar M: Vitamin D status and seasonal changes in plasma concentrations of 25-hydroxyvitamin D in office workers in Ankara, Turkey. Eur J Intern Med 2014, 25(2):197–201.
33.Leary PF, Zamfirova I, Au J, McCracken WH: Effect of Latitude on Vitamin D Levels. J Am Osteopath Assoc 2017, 117(7):433–439.